The Plasma microRNA miR-1914* and -1915 Suppresses Chemoresistant in Colorectal Cancer Patients by Down-regulating NFIX.

Publisher： Bentham Science Publishers

E-ISSN： 1875-5666|16|1|70-82

ISSN： 1566-5240

Source： Current Molecular Medicine, Vol.16, Iss.1, 2016-01, pp. : 70-82

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Clinicopathological and prognostic significance of the microRNA processing enzyme DICER1 mRNA expression in colorectal cancer patients

By Akahane  

Molecular and Clinical Oncology, Vol. 1, Iss. 2, 2013-01 ,pp. : 267-273

Spandidos Publications

Access to resources Recommend Favorite

Plasma miR200c and miR18a as potential biomarkers for the detection of colorectal carcinoma

By Zhang   Zhou   Liu   Tian   Xia  

Molecular and Clinical Oncology, Vol. 1, Iss. 2, 2013-01 ,pp. : 379-384

Spandidos Publications

Access to resources Recommend Favorite

Role of microRNA in Regulating Cell Signaling Pathways, Cell Cycle, and Apoptosis in Non-Small Cell Lung Cancer

By  

Current Molecular Medicine, Vol. 16, Iss. 5, 2016-06 ,pp. : 474-486

Bentham Science Publishers

Access to resources Recommend Favorite

Plasma Bmi1 mRNA as a potential prognostic biomarker for distant metastasis in colorectal cancer patients

By                    

Molecular and Clinical Oncology, Vol. 2, Iss. 5, 2014-01 ,pp. : 817-820

Spandidos Publications

Access to resources Recommend Favorite

miR221/222 in Cancer: Their Role in Tumor Progression and Response to Therapy

By  

Current Molecular Medicine, Vol. 12, Iss. 1, 2012-01 ,pp. : 27-33

Bentham Science Publishers

Access to resources Recommend Favorite